Pharmosa Biopharm Inc
TPEX:6875
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
P
|
Pharmosa Biopharm Inc
TPEX:6875
|
TW |
|
E
|
Elior Group SA
SWB:21E
|
FR |
|
G
|
Glow Lifetech Corp
OTC:GLWLF
|
CA |
Valor intrínseco
No hay suficientes datos para calcular de forma fiable el valor intrínseco de Pharmosa Biopharm Inc.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Análisis fundamental
Qué hace Pharmosa Biopharm
Pharmosa Biopharm, Inc. operates as a biotechnology company, which engages in the research, development, and sale of innovative drugs and medical equipment. The company is headquartered in Taipei City, Taipei. The company went IPO on 2022-02-22. The main products include L606, for the treatment of Category I pulmonary arterial hypertension (PAH); L606, for the treatment of Category III pulmonary hypertension caused by interstitial lung disease (PH-ILD); L606, for the treatment of chronic thromboembolic Category IV pulmonary hypertension (CTEPH); L608, for the treatment of Category I…
- Sede central
- Taiwán TW
- Empleados
- 39
- Fecha de salida a bolsa
- 22 feb., 2022